Mable Mutengo, Alejandro Dashti, Michaela Liptáková, Namwiinga R Mulunda, Freeman W Chabala, Kyoko Hayashida, Stanley Chinyanta, Kelly Chisanga, James Mwansa, Pamela C Köster, Mónica Santín, Javier Sotillo, Sergio Sánchez, David Carmena
{"title":"High prevalence of Enterocytozoon bieneusi (microsporidia) in asymptomatic schoolchildren, Zambia.","authors":"Mable Mutengo, Alejandro Dashti, Michaela Liptáková, Namwiinga R Mulunda, Freeman W Chabala, Kyoko Hayashida, Stanley Chinyanta, Kelly Chisanga, James Mwansa, Pamela C Köster, Mónica Santín, Javier Sotillo, Sergio Sánchez, David Carmena","doi":"10.1093/mmy/myaf065","DOIUrl":null,"url":null,"abstract":"<p><p>Microsporidia are single-celled, fungi-related eukaryotic intracellular parasites able to infect a wide diversity of invertebrate and vertebrate hosts. Among them, Enterocytozoon bieneusi and Encephalitozoon spp. (including Enc. cuniculi, Enc. hellem, and Enc. intestinalis) are known causative agents of infectious diseases in immunocompromised individuals, including HIV/AIDS patients and organ transplant recipients. Additionally, asymptomatic microsporidial infections seem more frequent than initially anticipated and might represent an overlooked public health threat. Here, we provide novel data on the occurrence and genetic diversity of microsporidial infections in individual stool samples (n = 247) collected from apparently healthy schoolchildren (age range: 5-18 years; male/female ratio: 1.1) in Lusaka, Zambia. Stool DNA samples were analysed by PCR and Sanger sequencing methods. A basic epidemiological questionnaire was used to retrieve data on variables potentially linked with higher odds of harbouring E. bieneusi infections. A high prevalence rate was found for E. bieneusi (9.3%, 23/247; 95% CI: 6.0-13.6), whereas Enc. intestinalis was much less frequent (0.4%, 1/247; 95% CI: 0.01-2.2). Four known (D, S2, S6, and Type IV) and three novel (HhZbEb1, HhZbEb2, and HhZbEb3) genotypes were identified within E. bieneusi. Genotype D was the predominant genotype found (30.8%, 4/13), followed by genotypes Type IV, HhZbEb2, and HhZbEb3 (15.4%, 2/13 each), and genotypes S2, S6, and HhZbEb1 (7.7%, 1/13 each). The only Encephalitozoon-positive sample was identified as Enc. intestinalis. Subclinical infections by E. bieneusi were common in the investigated paediatric population. Infected children could act as disregarded spreaders of microsporidial pathogens at the community level, thus representing a potential public health concern.</p>","PeriodicalId":18586,"journal":{"name":"Medical mycology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mmy/myaf065","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Microsporidia are single-celled, fungi-related eukaryotic intracellular parasites able to infect a wide diversity of invertebrate and vertebrate hosts. Among them, Enterocytozoon bieneusi and Encephalitozoon spp. (including Enc. cuniculi, Enc. hellem, and Enc. intestinalis) are known causative agents of infectious diseases in immunocompromised individuals, including HIV/AIDS patients and organ transplant recipients. Additionally, asymptomatic microsporidial infections seem more frequent than initially anticipated and might represent an overlooked public health threat. Here, we provide novel data on the occurrence and genetic diversity of microsporidial infections in individual stool samples (n = 247) collected from apparently healthy schoolchildren (age range: 5-18 years; male/female ratio: 1.1) in Lusaka, Zambia. Stool DNA samples were analysed by PCR and Sanger sequencing methods. A basic epidemiological questionnaire was used to retrieve data on variables potentially linked with higher odds of harbouring E. bieneusi infections. A high prevalence rate was found for E. bieneusi (9.3%, 23/247; 95% CI: 6.0-13.6), whereas Enc. intestinalis was much less frequent (0.4%, 1/247; 95% CI: 0.01-2.2). Four known (D, S2, S6, and Type IV) and three novel (HhZbEb1, HhZbEb2, and HhZbEb3) genotypes were identified within E. bieneusi. Genotype D was the predominant genotype found (30.8%, 4/13), followed by genotypes Type IV, HhZbEb2, and HhZbEb3 (15.4%, 2/13 each), and genotypes S2, S6, and HhZbEb1 (7.7%, 1/13 each). The only Encephalitozoon-positive sample was identified as Enc. intestinalis. Subclinical infections by E. bieneusi were common in the investigated paediatric population. Infected children could act as disregarded spreaders of microsporidial pathogens at the community level, thus representing a potential public health concern.
期刊介绍:
Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.